Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Eszopiclone 3mg tablets
0401010AEAAACAC
|
Eszopiclone | Eszopiclone | Central Nervous System | No data available |
|
Etamsylate 250mg/2ml solution for injection ampoules
0211000D0AAAAAA
|
Etamsylate | Etamsylate | Cardiovascular System | No data available |
|
Etamsylate 500mg/5ml oral solution
0211000D0AAAEAE
|
Etamsylate | Etamsylate | Cardiovascular System | No data available |
|
Etanercept 10mg inj vials
1001030D0AAAFAF
|
Etanercept | Etanercept | Musculoskeletal and Joint Diseases | No data available |
|
Etanercept 25mg inj vials
1001030D0AAAAAA
|
Etanercept | Etanercept | Musculoskeletal and Joint Diseases | No data available |
|
Etanercept 25mg/0.5ml inj pre-filled syringes
1001030D0AAADAD
|
Etanercept | Etanercept | Musculoskeletal and Joint Diseases | No data available |
|
Etanercept 50mg inj vials
1001030D0AAABAB
|
Etanercept | Etanercept | Musculoskeletal and Joint Diseases | No data available |
|
Ethambutol 100mg/5ml oral solution
0501090H0AABDBD
|
Ethambutol hydrochloride | Ethambutol hydrochloride | Infections | No data available |
|
Ethambutol 125mg/5ml oral solution
0501090H0AABFBF
|
Ethambutol hydrochloride | Ethambutol hydrochloride | Infections | No data available |
|
Ethambutol 150mg/5ml oral solution
0501090H0AABCBC
|
Ethambutol hydrochloride | Ethambutol hydrochloride | Infections | No data available |
|
Ethambutol 150mg/5ml oral suspension
0501090H0AABHBH
|
Ethambutol hydrochloride | Ethambutol hydrochloride | Infections | No data available |
|
Ethambutol 200mg/5ml oral liquid
0501090H0AAAVAV
|
Ethambutol hydrochloride | Ethambutol hydrochloride | Infections | No data available |
|
Ethambutol 250mg/5ml oral liquid
0501090H0AABABA
|
Ethambutol hydrochloride | Ethambutol hydrochloride | Infections | No data available |
|
Ethambutol 25mg/5ml oral solution
0501090H0AAAWAW
|
Ethambutol hydrochloride | Ethambutol hydrochloride | Infections | No data available |
|
Ethambutol 350mg/5ml oral solution
0501090H0AAAYAY
|
Ethambutol hydrochloride | Ethambutol hydrochloride | Infections | No data available |
|
Ethambutol 375mg/5ml oral solution
0501090H0AAATAT
|
Ethambutol hydrochloride | Ethambutol hydrochloride | Infections | No data available |
|
Ethambutol 400mg/5ml oral liquid
0501090H0AAASAS
|
Ethambutol hydrochloride | Ethambutol hydrochloride | Infections | No data available |
|
Ethambutol 450mg/5ml oral solution
0501090H0AABBBB
|
Ethambutol hydrochloride | Ethambutol hydrochloride | Infections | No data available |
|
Ethambutol 500mg/5ml oral liquid
0501090H0AAARAR
|
Ethambutol hydrochloride | Ethambutol hydrochloride | Infections | No data available |
|
Ethambutol 50mg/5ml oral solution
0501090H0AABGBG
|
Ethambutol hydrochloride | Ethambutol hydrochloride | Infections | No data available |
|
Ethambutol 600mg/5ml oral liquid
0501090H0AAAXAX
|
Ethambutol hydrochloride | Ethambutol hydrochloride | Infections | No data available |
|
Ethambutol 700mg/5ml oral solution
0501090H0AABEBE
|
Ethambutol hydrochloride | Ethambutol hydrochloride | Infections | No data available |
|
Ethambutol 700mg/5ml oral suspension
0501090H0AABIBI
|
Ethambutol hydrochloride | Ethambutol hydrochloride | Infections | No data available |
|
Ethanol 100% solution for injection 2ml ampoules
190100000AAABAB
|
Generic compound preparation BNF 1901000 | Other alcohol, wine and spirit preparations | Other Drugs and Preparations | No data available |
|
Ethanol 100% solution for injection 5ml ampoules
190100000AAAAAA
|
Generic compound preparation BNF 1901000 | Other alcohol, wine and spirit preparations | Other Drugs and Preparations | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.